Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 1, 2013, Pages 80-90

  Ahmadzadehfar, Hojjat ^a   Meyer, Carsten ^a   Ezziddin, Samer ^a   Sabet, Amir ^a   Hoff Meyer, Anja ^a   Muckle, Marianne ^a   Logvinski, Timur ^a   Schild, Hans Heinz ^a   Biersack, Hans Jürgen ^a   Wilhelm, Kai ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Liver metastases; Radioembolization; Resin microspheres; SIRT

Indexed keywords

MICROSPHERE; RESIN; YTTRIUM 90;

ADULT; AGED; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERTROPHY; LIVER FUNCTION; LIVER LOBECTOMY; LIVER METASTASIS; LIVER RESECTION; LIVER WEIGHT; MALE; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; CASE-CONTROL STUDIES; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYPERTROPHY; LIVER; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; ORGAN SIZE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SPLEEN; YTTRIUM RADIOISOTOPES;

EID: 84875714487     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2253-2     Document Type: Review

References (34)

1. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251-78. doi: 10.1097/01.RVI.0000233785.75257.9A.
2. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818-25. discussion 25-7.
3. Sangro B, Carpanese L, Cianni R, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation. Hepatology. 2011;54:868-78. doi: 10.1002/hep.24451.
4. Mulcahy MF, Lewandowski RJ, Ibrahim SM, et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer. 2009;115:1849-58. doi: 10.1002/cncr.24224.
5. Rhee TK, Lewandowski RJ, Liu DM, et al. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg. 2008;247:1029-35. doi: 10.1097/SLA.0b013e3181728a4500000658-200806000-00017.
6. Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65:412-25. doi: 10.1016/j.ijrobp.2005.12.051.
7. Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med. 2010;40:105-21. doi: 10.1053/j.semnuclmed.2009.11.001.
8. Gaba RC, Lewandowski RJ, Kulik LM, et al. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol. 2009;16:1587-96. doi: 10.1245/s10434-009- 0454-0.
9. Seidensticker R, Seidensticker M, Damm R, et al. Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol. 2012;35:1109-18. doi: 10.1007/s00270-011-0295-7.
10. Gulec SA, Pennington K, Hall M, Fong Y. Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J Surg Oncol. 2009;7:6. doi: 10.1186/1477-7819-7-6.
11. Jakobs TF, Saleem S, Atassi B, et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig Dis Sci. 2008;53:2556-63. doi: 10.1007/s10620-007-0148-z.
12. Sabet A, Ahmadzadehfar H, Muckle M, et al. Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization. J Nucl Med. 2011;52:1063-7. doi: 10.2967/jnumed.110.083626.
13. Ahmadzadehfar H, Sabet A, Biermann K, et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med. 2010;51:1206-12. doi: 10.2967/jnumed.109.074559.
14. Ahmadzadehfar H, Mohlenbruch M, Sabet A, et al. Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with (99m)Tc-MAA accumulation in the anterior abdominal wall? Eur J Nucl Med Mol Imaging. 2011;38:1477-84. doi: 10.1007/s00259-011-1807-z.
15. Ahmadzadehfar H, Muckle M, Sabet A, Wilhelm K, Kuhl C, Biermann K. The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects. Eur J Nucl Med Mol Imaging. 2012;39:309-15. doi: 10.1007/s00259-011-1940-8.
16. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S-50. doi: 10.2967/jnumed.108.057307.
17. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-47. doi: 10.1016/j.ejca.2008.10.026.
18. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176-81. doi: 10.1016/S1053-4296(03)00031-6.
19. Denys A, Prior J, Bize P, Duran R, De Baere T, Halkic N, et al. Portal vein embolization: what do we know? Cardiovasc Intervent Radiol. 2012;35:999-1008. doi: 10.1007/s00270-011-0300-1.
20. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759-66.
21. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197:29-37. doi: 10.1016/S1072-7515(03)00230-8.
22. Howlader M, Heaton N, Rela M. Resection of liver metastases from breast cancer: towards a management guideline. Int J Surg. 2011;9:285-91. doi: 10.1016/j.ijsu.2011.01.009.
23. Anaya DA, Blazer DG, Abdalla EK. Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol. 2008;25:110-22. doi: 10.1055/s-2008-1076684.
24. Sturesson C, Keussen I, Tranberg KG. Prolonged chemotherapy impairs liver regeneration after portal vein occlusion - an audit of 26 patients. Eur J Surg Oncol. 2010;36:358-64. doi: 10.1016/j.ejso.2009.12.001.
25. Covey AM, Brown KT, Jarnagin WR, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451-5. doi: 10.1097/SLA. 0b013e31815ed693.
26. Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol. 2008;15:2765-72. doi: 10.1245/s10434-008-0035-7.
27. Beal IK, Anthony S, Papadopoulou A, et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol. 2006;79:473-8. doi: 10.1259/bjr/29855825.
28. Tellez C, Benson 3rd AB, Lyster MT, et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998;82:1250-9.
29. Vogl TJ, Zangos S, Balzer JO, Thalhammer A, Mack MG. Transarterial chemoembolization of liver metastases: indication, technique, results. Rofo. 2002;174:675-83. doi: 10.1055/s-2002-32228.
30. Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011;140:497-507. doi: 10.1053/j.gastro.2010.10.049.
31. Lewandowski RJ, Kulik LM, Riaz A, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant. 2009;9:1920-8. doi: 10.1111/j.1600-6143. 2009.02695.x.
32. Vogl TJ, Mack MG, Balzer JO, et al. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology. 2003;229:457-64. doi: 10.1148/radiol.2292021329.
33. Nosher JL, Ohman-Strickland PA, Jabbour S, Narra V, Nosher B. Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres. J Vasc Interv Radiol. 2011;22:1706-13. doi: 10.1016/j.jvir.2011.08.017.
34. Paprottka PM, Schmidt GP, Trumm CG, Hoffmann RT, Reiser MF, Jakobs TF. Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance. Cardiovasc Intervent Radiol. 2011;34:964-72. doi: 10.1007/s00270-011-0217-8.